Thermo Fisher Scientific Publishes 2020 Corporate Social Responsibility Report

- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today published its 2020 Corporate Social Responsibility (CSR) report, reflecting its commitment to society, stakeholders and environmental, social and governance (ESG) efforts. The report provides detailed insight into the company's approach to CSR, outlines future priorities and highlights achievements across four pillars of focus: operations, colleagues, communities and environment.

Thermo Fisher Scientific is the world leader in serving science and with that position comes a great sense of responsibility to the global community. We have the ability to make a significant positive impact on society. Learn more about our initiatives in our 2020 Corporate Social Responsibility Report.

"Across Thermo Fisher Scientific, we hold ourselves accountable for doing business the right way and delivering on our responsibility to society," said Marc N. Casper , chairman, president and chief executive officer of Thermo Fisher Scientific. "From our mobilization to assist in the global response to the COVID-19 pandemic, our expanded D&I programs, our support of non-profit organizations and global health equity initiatives and our commitments to reduce greenhouse gas emissions, I'm proud to share all that our 90,000 colleagues accomplished in 2020."

Highlights from the company's 2020 CSR efforts include:

Operations

  • Mobilized significant resources and worked with speed at scale to accelerate the development, manufacturing and distribution of critical products and services in support of the societal response to the pandemic including more than 700 million PCR-based COVID-19 tests
  • Drove opportunity and equity through our world-class supply chain with $1.3 billion spent with businesses owned by women, minorities, veterans and members of the disabled and LGBTQ communities

Colleagues

  • Enhanced programming to support the company's more than 90,000 colleagues with robust training, talent development opportunities and increased retention efforts including a special pandemic response compensation structure
  • Advanced progress towards diversity and inclusion priorities and disclosures, with women comprising 40% of all global leadership hires

Communities

  • Invested $30 million to establish the Foundation for Science with a focus on enabling STEM education access for underserved groups and supported more than 2,900 not-for-profits through our global network of colleagues
  • In addition to a $25 million COVID-19 testing program to enable the safe reopening of historically black colleges and universities in the U.S., we partnered with global health organizations to ensure that more than 100 low- and middle-income countries had access to critical pandemic response supplies

Environment

  • Made progress on the company's 2050 net-zero goal and 2030 target to reduce greenhouse gas emissions across operations by 30% (from 2018 levels) and advancing our renewable energy strategy

Learn more about Thermo Fisher's commitment to CSR and our progress here www.thermofisher.com/csr

About Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $35 billion . Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, improving patient diagnostics and therapies or increasing productivity in their laboratories, we are here to support them. Our global team of more than 90,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services and Patheon. For more information, please visit www.thermofisher.com .

Media Contact Information:
Ron O'Brien
Phone: 781-622-1242
E-mail: ron.obrien@thermofisher.com

Investor Contact Information:
Rafael Tejada
Phone:  781-622-1356
E-mail: rafael.tejada@thermofisher.com

Cision View original content to download multimedia: https://www.prnewswire.com/news-releases/thermo-fisher-scientific-publishes-2020-corporate-social-responsibility-report-301408115.html

SOURCE Thermo Fisher Scientific

News Provided by Canada Newswire via QuoteMedia

The Conversation (0)
illustration of brain and cell phone.

BlinkLab Completes First Patient Test for US Autism Diagnostic Study

Digital healthcare company BlinkLab (ASX:BB1) has tested the first patient in its US autism diagnostic study, which is geared at validating the company's Dx1 test as a diagnostic aid for clinicians.

BlinkLab states in its Wednesday (March 12) release that the study is the largest digital diagnostic trial for autism in the US, with its aim being to support the early detection of developmental conditions like autism.

The first patient test took place at PriMED Clinical Research in Dayton, Ohio. PriMED, a division of PriMED Physicians, is one of two clinical sites selected for the study’s initial phase, which is targeting 100 patients.

Keep reading...Show less
HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Signs Strategic Collaboration Agreement with Garmin Health

HeraMED Limited (ASX: HMD), a medical data and technology company leading the digital transformation of maternity care, is delighted to announce it has entered into a collaboration agreement with Garmin (NYSE: GRMN), a leading global provider of smartwatches and GPS-enabled products, aimed at enhancing remote pregnancy monitoring and expanding the range of health data available to expectant mothers and their healthcare providers.

Keep reading...Show less
Cardiologist wearing virtual reality glasses.

2 Biggest Medical Device ETFs in 2025

Exchange-traded funds (ETFs) are a popular investment strategy, and generally contain a variety of publicly traded companies under one stock symbol, often with a focus on a specific sector.

Depending on the ETF, investors may be able to track up-and-coming companies, get exposure to top firms or a mix of both. Aside from stocks, some ETFs also track commodities or bonds.

In the healthcare industry, medical device ETFs bring together companies that go to great lengths to develop pharmaceutical-based technology that can improve the lives of patients.

Keep reading...Show less
Cyclomedica

Cyclopharm Signs US Agreement with HCA Healthcare for Technegas®

Cyclopharm Limited (ASX: CYC) is pleased to announce the signing of a major contract with Hospital Corporation of America Healthcare (HCA), one of the largest single healthcare providers in the United States. This agreement marks a significant milestone for the company which will allow the deployment of Technegas® in up to 169 nuclear medicine departments across HCA’s extensive network.1

Keep reading...Show less
CONNEQT App Launches in USA as Pulse Deliveries Commence

CONNEQT App Launches in USA as Pulse Deliveries Commence

Cardiex Limited (CDX:AU) has announced CONNEQT App Launches in USA as Pulse Deliveries Commence

Download the PDF here.

Female doctor with clipboard talking to smiling female patient at hospital.

Revolutionizing Women's Health: Antifungal Innovation Brings New Investment Opportunities

The intersection of women's health and antifungal innovation represents a pivotal moment in healthcare, offering both transformative medical advancements and compelling investment opportunities.

The groundbreaking developments in antifungal treatments specifically targeting women's health issues present a substantial market potential, resulting in rising investor interest in this rapidly evolving sector.

Despite comprising half the global population, women face unique health challenges that have historically received insufficient attention and investment. Among these health challenges, vaginal candidiasis stands out as a persistent and widespread issue affecting millions of women worldwide.

Keep reading...Show less

Latest Press Releases

Related News

×